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Abstract
Background: This study investigated the differences in caregiver activity, caregiver burden, and awareness of both
caregivers and patients with Alzheimer’s disease (AD) across different Asian locations.
Methods: This was a secondary analysis of a multi-national cohort study that aimed to assess caregiver activity and
caregiver burden using the Caregiver Activity Scale (CAS) and Zarit Burden Interview (ZBI), respectively. Patients’
awareness of their dementia diagnosis was assessed by asking the following yes/no question: “Do you have
dementia?” Caregivers’ awareness of the patient’s dementia diagnosis was assessed by asking the following yes/no
question: “Does your patient have dementia?”
Results: In total, 524 caregivers of patients with AD from China, Hong Kong, South Korea, the Philippines, Singapore,
Thailand, and Taiwan participated. The CAS and ZBI score were significantly different across most locations (p < 0.001
and p = 0.033, respectively). Overall, 56.6% of caregivers and 37.5% of patients had awareness of the dementia
diagnosis, and the proportion of patients and caregivers with awareness were also different between each location (all,
p < 0.001).
Conclusions: Caregiving, caregiver burden, and the awareness of caregivers and patients were different across many
Asian locations. With understanding of cultural differences, further public education on dementia could help increase
the awareness of patients and caregivers and reduce caregiver burden.
Trial registration: ClinicalTrials.gov, NCT02262975. Registered 13 October 2014,
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Background
According to the World Alzheimer Report 2015, demen-
tia currently affects more than 46 million people world-
wide and this number is estimated to increase to 131.5
million by 2050 [1]. In comparison to 2009 estimates,
the estimated prevalence of dementia has increased in
Asia and Africa but decreased in Europe and in the
United States [1]. In 2005, the Delphi Consensus Report
estimated that 48% of dementia patients live in Asia and
that this percentage is estimated to grow to 59% by 2050
[2]. Therefore, countries in Asia face a greater propor-
tion of the global burden.
The World Alzheimer Report also reported that the
majority of patients with dementia are still living at
home, and that 94% of people living with dementia in
low- and middle-income countries are cared for at home
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[1]. Therefore, those often directly involved in the care
of dementia patients are their families, and as a result,
dementia has a strong impact on the wellbeing, func-
tioning and quality of life of not only home-dwelling
dementia patients but also their family caregivers [1]. Ef-
forts should be made to determine what factors affect
caregiving activity and caregiver burden and what mea-
sures are necessary to reduce them.
A large proportion of patients with Alzheimer’s disease
(AD) have anosognosia (i.e., denial, impaired awareness
or a lack of awareness of their cognitive deficits, functional
limitations, and disease-related behavioral changes) [3–5].
The prevalence of anosognosia in AD varies between 20
and 80%, although this is dependent on factors such as the
assessment method used, sample characteristics, and the
severity of dementia [5]. In addition to the poor awareness
of patients themselves, the awareness of caregivers can
also affect the prognosis of patients with dementia as well
as caregiver burden [6]. For example, Boise et al. found
that caregivers delayed seeking a diagnosis because they
lacked information about dementia; caregivers believed
symptoms were signs of normal aging [7]. Caregivers were
also generally overwhelmed by the situation and did not
know which physician to ask [7]. Therefore, poor aware-
ness of both the patient and caregiver may significantly
affect the prognosis and caregiving of dementia patients.
Caregiver burden, caregiver awareness, and patient
awareness are also influenced by cultural and socioeco-
nomic factors [8, 9]. In Asia, there is a cultural diversity
that is likely to significantly affect caregiver burden and
the awareness of dementia patients and their family
caregivers. During the original study, the Caregiver Ac-
tivity Scale (CAS), the Zarit Burden Interview (ZBI), and
simple questions about awareness of the disease were
conducted at baseline. A secondary analysis of the re-
sults of these surveys was conducted to investigate care-
giver burden, caregiver awareness, and patient awareness
in seven Asian locations, and whether cultural diversity
had any effect.
Methods
Original study design and cohort
The original cohort study was a multi-national trial to
identify treatment discontinuation rates in de novo
Alzheimer’s disease patients who have been newly pre-
scribed with DOnepezil in ASia (ADOS) (NCT02262975).
In brief, the original study was conducted on patients who
met the National Institute of Neurological and Communi-
cative Disorders and Stroke and the Alzheimer’s Disease
and Related Disorders Association criteria [10] for prob-
able AD and were aged between 50 and 90 years. Inclusion
criteria included patients who were prescribed donepezil
monotherapy for the first time and who had a caregiver
who could accompany them to the hospital. In total, 527
patients from 38 institutions across seven countries in
Asia (see Appendix) were included in the original study.
Among them, three caregivers did not assess the caregiver
questionnaire. Therefore, in this analysis, data from 524
caregivers were analyzed.
The original study was performed between July 2014
and August 2016 and conducted in accordance with
Good Clinical Practice (GCP) and the Declaration of
Helsinki as well as with the regulations of the Inter-
national Conference on Harmonisation. The Institu-
tional Review Board guidelines of each center were
adhered to in all research centers, and written informed
consent was obtained from all patients and caregivers
who participated in the study.
Survey assessments
In the current analysis we investigated caregivers and
patients with AD dementia from seven Asian geographic
locations (China, Hong Kong, the Philippines, Singapore,
South Korea, Taiwan, and Thailand). General demo-
graphic and background characteristics including care-
giving activities, social support, and social activities of
the caregiver were recorded at the first visit. The clinical
characteristics of patients were also recorded including a
mini-mental state exam (MMSE) score [11] and clinical
dementia rating (CDR) [12].
This analysis used the CAS [13] and the ZBI [14] to
assess caregivers of patients who participated in the
ADOS study. The ZBI is one of the most commonly
used scales for assessing the burden of caregivers who
provide care for dementia patients, with a higher score
indicating a greater burden [15]. The ZBI is a 22-item
questionnaire measuring subjective burden, which has
demonstrated high consistency and validity. The CAS
was used to collect information regarding the time care-
givers spent providing care during a typical 24-h period,
with increased time indicative of greater burden. The
clinical characteristics of the patients and caregivers
were then used to determine the presence of any na-
tional or cultural differences in CAS and ZBI survey
data. Survey information was collected at baseline and
was not affected by whether or not participants com-
pleted a follow-up visit.
Additionally, patients’ awareness of their dementia
diagnosis was assessed by asking the following yes/no
question: “Do you have dementia?” Caregivers’ aware-
ness of the patient’s dementia diagnosis was assessed by
asking the following yes/no question: “Does your patient
have dementia?” The CAS and ZBI scores and patient
and caregiver awareness were compared between Asian
locations to determine which demographic and clinical
characteristics of the caregivers and patients affected
caregiver burden. These assessments were performed be-
fore the initial prescription of donepezil.
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Statistical analyses
A two-sample t-test and an analysis of variance
(ANOVA) were used as parametric hypothesis tests
while analyzing differences between two and three
groups, respectively. For non-parametric hypothesis test-
ing, a Wilcoxon’s rank sum test and a Kruskal–Wallis
test were used to test differences between two and three
or more groups, respectively. A Fisher’s exact test with
Monte Carlo simulation and Pearson’s Chi-square test
(χ2) were used to compare percentages. To analyze the
association between patients, caregiver awareness, ZBI,
and CDR scores, linear regression and logistic regression
methods were used. The statistical significance threshold
was set to α = 0.05 with a 95% confidence level. Statis-
tical analyses were performed using SAS® software (ver-
sion 9.3; SAS Institute Inc., Cary, NC, USA).
Results
Background characteristics of caregivers and patients
In the original study, 524 caregivers of patients with AD
were recruited from China (n = 101), Hong Kong (n =
10), South Korea (n = 259), the Philippines (n = 23),
Singapore (n = 52), Thailand (n = 6), and Taiwan (n = 73)
(Table 1). The overall mean age of caregivers was
59.17 ± 15.35 years with the oldest age in Hong Kong
(80.20 ± 6.88 years) and the lowest age in the Philippines
(46.30 ± 14.23 years). In total, 61.3% of caregivers were
female; however, there were more male caregivers in
China (53.5%) and Taiwan (52.1%). The mean duration
of education of caregivers was 11.58 ± 5.20 years, with
longer durations of education in the Philippines (15.17 ±
2.87 years) and shorter durations of education in Hong
Kong (3.00 ± 4.55 years) and Thailand (3.00 ± 1.73 years).
There were significant differences across all seven loca-
tions for mean age, sex, marriage status, duration of edu-
cation, employment status, and relationship to the
patient (all, p < 0.001). In general, caregivers were the
spouse (35.3%), daughter (29.4%), or son (21.5%). The
percentage of children as caregivers was 58.9%, if son,
daughter, or son- or daughter-in-law were included;
however, there were significant differences between loca-
tions (p = 0.005).
Table 2 describes the demographic and clinical charac-
teristics of patients. Overall, patients mean age was
75.68 ± 7.07 years. The mean MMSE score was 18.66 ±
5.45 (n = 504), and the mean CDR (global) was 0.94 ±
0.53 (n = 522; range 0.5–3) in the overall population.
Caregiver activity scale and Zarit burden interview score
Figure 1 illustrates the CAS and ZBI scores obtained in
each location. The CAS score (p < 0.001) and ZBI score
(p = 0.033) were significantly different between each
location.
Linear regression analysis showed that in all studied
locations, the CAS score was generally higher for pa-
tients who were male, overweight, and/or tall and who
were cared for by an older caregiver, unemployed care-
giver, poorly educated caregiver, non-child caregiver, or
a caregiver who resided with them (Table 3). Addition-
ally, in China, the CAS score was high if the patient had
a severe CDR (n = 96; estimate 137.96 ± 58.37, p = 0.02).
In Singapore, the CAS score was high if the caregiver
was unmarried (n = 49; estimate 392.76 ± 110.21, p =
0.001), or if the patient was aware of their illness (n = 49;
estimate 209.15 ± 93.88, p = 0.031). In the Philippines,
the CAS score was higher according to the lower MMSE
score (n = 23; estimate − 62.60 ± 14.81, p < 0.001) and the
more severe CDR (n = 23; estimate 678.90 ± 183.87, p =
0.001) of the patients.
Generally, in all studied locations, the ZBI score was
high if the patient was male or old, with a low MMSE
score and a high CDR, and if the caregiver was female or
cohabiting with the patient (Table 3). The patient’s
awareness of the illness was unrelated, but the ZBI score
was high if the caregiver was aware of the patient’s de-
mentia. Specifically, in South Korea, the ZBI score was
high if the caregiver’s duration of education was short
(n = 247; estimate − 0.51 ± 0.19, p = 0.008), and the care-
giver was unemployed (n = 256; estimate 4.71 ± 2.05, p =
0.023). In Singapore, the ZBI score was high if the pa-
tient was unaware of the illness (n = 52; estimate 16.08 ±
3.61, p < 0.001). In Hong Kong, the ZBI score was high if
the caregiver was spouse of the patients, not the child
(n = 8; estimate − 33.50 ± 12.58, p = 0.037).
Awareness of caregivers and patients
The awareness of patients and caregivers of the patients’
dementia diagnosis differed by location (Fig. 2). Overall,
56.5% of caregivers and 37.4% of patients had awareness;
however, in Hong Kong and the Philippines, 100.0% of
caregivers had awareness. In contrast, 49.0 and 41.7% of
caregivers in China and South Korea had awareness, re-
spectively. The proportion of patients with awareness
were 80.0 and 78.3% in Hong Kong and the Philippines,
respectively, followed by Thailand (66.7%), Singapore
(57.7%), Taiwan (52.8%), China (35.7%), and South
Korea (23.6%), in descending order (p < 0.001).
Logistic regression analysis showed that, in general,
patients were likely to have awareness if they were fe-
male and if their caregiver was young, educated or their
child (Table 4). Furthermore, patients had awareness if
their caregiver also had awareness. Specifically, in
Taiwan and Singapore, patients had awareness if there
was a high MMSE score (n = 73; estimate 0.10 ± 0.05,
odds ratio [OR] 1.102 [95% confidence interval (CI):
1.002–1.213, p = 0.046] and n = 51; estimate ± SE, 0.22 ±
0.08, OR 1.245 [95% CI: 1.064–1.456, p = 0.006],
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respectively), and not so severe CDR_SOB (n = 73; esti-
mate − 0.17 ± 0.08, OR 0.847 [95% CI: 0.726–0.988, p =
0.035 and n = 52; estimate − 0.44 ± 0.16, OR 0.642 [95%
CI: 0.470–0.877, p = 0.005], respectively). In addition, in
Singapore, the lower the CDR (n = 52; estimate − 2.28 ±
0.85, OR 0.102 [95% CI: 0.019–0.543, p = 0.007]) and the
lower the ZBI (n = 52; estimate − 0.09 ± 0.26, OR 0.915
[95% CI: 0.870–0.962, p = 0.001]), the more likely the pa-
tients were to have awareness. In China and South
Korea, patients’ awareness was inversely proportional to
caregivers’ awareness (n = 98; estimate − 0.88 ± 0.43, OR
0.415 [95% CI: 0.178–0.971, p = 0.042] and n = 258; esti-
mate − 2.06 ± 0.35, OR 0.128 [95% CI: 0.064–0.254, p <
0.001], respectively).
Caregivers were more likely to have awareness if
the patient was female, older, and severely demented
and if the caregiver was young, had a longer duration
of education, and had a high ZBI score (Table 4).
Caregivers’ awareness was inversely proportional to
patients’ awareness (Table 5), and caregivers were
Table 2 Demographic and clinical characteristics of patients with dementia




(n = 524) (n = 259) (n = 101) (n = 73) (n = 52) (n = 23) (n = 10) (n = 6)
Age, years 75.68 ± 7.07 75.21 ± 6.89 74.61 ± 7.26 76.85 ± 7.42 75.65 ± 7.19 78.52 ± 4.52 80.20 ±
6.88
81.17 ± 8.04 0.01
Sex (male:
female)
203:321 117:142 36:65 20:53 15:37 10:13 4:6 1:5 0.053
Duration of
education, years
7.22 ± 5.33 6.36 ± 4.83 9.87 ± 5.37 6.33 ± 4.63 5.13 ± 4.75 14.39 ± 3.94 3.20 ±
4.96
8.00 ± 6.23 <
0.001
MMSE score 18.66 ± 5.45 (n
= 504)
19.93 ± 4.73 (n
= 255)
18.16 ± 6.25 (n
= 99)
16.41 ± 5.23 (n
= 73)
17.00 ± 5.07 (n
= 51)
17.96 ± 6.83 (n
= 23)
14.67 ±
8.39 (n = 3)
<
0.001






































Data are presented as n or mean ± standard deviation
CDR Clinical dementia rating, CDR-SOB Clinical dementia rating-sum of boxes, MMSE Mini-mental state exam
Fig. 1 Mean caregiver activity scale (CAS) and Zarit burden interview (ZBI) scores
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Table 3 Caregiver activity scale (CAS) and Zarit burden interview (ZBI) scores
CAS ZBI
Variables n Estimate Standard error p-value n Estimate Standard error p-value
Patient’s sex (female) 495 − 387.0084 68.662 < 0.0001 521 −3.3414 1.448 0.021
Patient’s age 495 4.8481 4.824 0.3154 521 0.2237 0.1 0.026
Patient’s duration of education 495 4.8044 6.423 0.4548 521 0.0065 0.133 0.961
Patient’s weight 450 12.4228 3.07 < 0.0001 472 0.0583 0.07 0.407
Patient’s height 449 14.5499 3.337 < 0.0001 471 0.1289 0.077 0.097
MMSE 476 9.7593 6.475 0.1324 501 −0.455 0.13 < 0.001
CDR (sum of boxes) 493 16.0826 10.847 0.1388 519 1.7492 0.21 < 0.001
CDR (global) 493 94.7484 65.635 0.1495 519 9.9107 1.275 < 0.001
Patient’s awareness (none) 487 117.4496 71.767 0.1024 508 1.0642 1.469 0.469
Caregiver’s sex (female) 495 131.9129 70.314 0.0612 521 3.5599 1.447 0.014
Caregiver’s age 486 6.8393 2.24 0.0024 511 0.0415 0.046 0.370
Caregiver’s duration of education 484 −29.3388 6.587 < 0.0001 503 −0.0846 0.138 0.541
Caregiver’s occupation (none) 484 226.7616 69.114 0.0011 509 2.1644 1.435 0.132
Caregiver’s marital status (single) 494 66.7254 113.298 0.5562 518 −1.0485 2.326 0.652
Caregiver’s awareness (none) 494 36.5177 69.646 0.6003 517 −6.3056 1.41 < 0.001
Relationship with caregiver (child) 426 − 431.9034 75.527 < 0.0001 448 −1.6973 1.516 0.267
Cohabitation (no) 493 − 357.2101 69.206 < 0.0001 519 −5.4699 1.446 < 0.001
CDR Clinical dementia rating, MMSE Mini-mental state exam
Fig. 2 Proportion of caregivers and patients with awareness
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more likely to have awareness if they were the pa-
tient’s children rather than spouse. Specifically, in
China, caregivers’ awareness was high if the CDR was
high (n = 101; estimate ± SE, 1.47 ± 0.39, OR 4.329
[95% CI: 2.005–9.349, p < 0.001]), and this was in-
versely proportional to patients’ awareness (n = 98; es-
timate − 0.88 ± 0.43, OR 0.415 [95% CI: 0.178–0.971,
p = 0.043]).
Discussion
The present study showed that 56.6% of caregivers had
awareness of their patient’s dementia and 37.4% of pa-
tients were aware of their dementia, and that patients’
and caregivers’ awareness were mutually influential. Pa-
tients were more likely to be aware of their dementia if
they were female and the caregiver was young, highly
educated, and one of the patient’s children. From the
caregivers’ perspective, high awareness was achieved if
they were young, female, highly educated, and one of
the patient’s children, and if the patient was highly
demented.
The CAS score was more likely to be high if the pa-
tient was male, overweight, and tall and if the caregiver
was old, poorly educated, unemployed, the spouse, the
primary caregiver, or cohabiting with the patient. The
ZBI score was more likely to be high if the patient was
male, old, severely demented, or with dysfunctional cog-
nitive skills and if the caregiver was female, cohabiting
with the patient, the primary caregiver, and if the care-
giver was aware of the patient’s illness. Interestingly, pa-
tients’ awareness of their illness did not significantly
influence caregiver CAS and ZBI scores; however, the
ZBI score was high when the caregiver was aware of the
patient’s illness.
The factors that influence CAS and ZBI scores were
similar to what has been previously published in other
studies. Caregivers who are of an advanced age [16, 17],
are female [18–20], and are cohabiting with the patient,
Table 4 Factors that influence the awareness of caregivers and patients
Variables Patient awareness Caregiver awareness
n Estimate Standard Odds Odds Ratio p-value n Estimate Standard Odds Odds Ratio p-value
Error Ratio [95% CI] Error Ratio [95% CI]
Patient’s sex (female) 524 0.4008 0.1897 1.493 [1.029,2.165] 0.0346 524 0.4205 0.1808 1.523 [1.068,2.170] 0.02
Patient’s age 524 −0.0097 0.0128 0.99 [0.966,1.016] 0.4486 524 0.0429 0.0128 1.044 [1.018,1.070] < 0.001
Patient’s duration of education 524 0.0119 0.017 1.012 [0.979,1.046] 0.4842 524 −0.0195 0.0165 0.981 [0.949,1.013] 0.237
MMSE 504 0.0146 0.0172 1.015 [0.981,1.050] 0.3981 504 −0.1166 0.0187 0.89 [0.858,0.923] < 0.001
CDR-SOB 522 −0.0508 0.0299 0.95 [0.896,1.008] 0.0891 522 0.2566 0.0379 1.292 [1.200,1.392] < 0.001
CDR (global) 522 −0.2392 0.1787 0.787 [0.555,1.118] 0.1808 522 1.3555 0.2243 3.879 [2.499,6.021] < 0.001
Patient’s awareness (no) 511 −1.7293 0.2152 0.177 [0.116,0.270] < 0.001
Caregiver’s sex (female) 524 0.1176 0.1869 1.125 [0.780,1.622] 0.5292 524 −0.036 0.1808 0.965 [0.677,1.375] 0.842
Caregiver’s age 514 −0.0172 0.0061 0.983 [0.971,0.995] 0.0045 514 −0.0136 0.0059 0.986 [0.975,0.998] 0.020
Caregiver’s duration of education 505 0.0543 0.0185 1.056 [1.018,1.095] 0.0033 505 0.0373 0.0175 1.038 [1.003,1.074] 0.032
Caregiver’s occupation (none) 512 −0.0926 0.1844 0.912 [0.635,1.309] 0.6158 512 −0.2444 0.1798 0.783 [0.551,1.114] 0.174
Marital status of caregiver (single) 521 0.5398 0.2891 1.716 [0.974,3.023] 0.0619 521 0.4911 0.3033 1.634 [0.902,2.961] 0.105
Relationship with caregiver (child) 449 0.6964 0.2052 2.006 [1.342,3.000] 0.0007 449 0.6053 0.1943 1.832 [1.252,2.681] 0.002
Cohabitation (no) 521 −0.0561 0.1876 0.945 [0.655,1.366] 0.765 521 0.0402 0.1822 1.041 [0.728,1.488] 0.826
Primary caregiver (no) 515 0.0569 0.2012 1.059 [0.714,1.570] 0.7772 515 0.064 0.1967 1.066 [0.725,1.568] 0.745
CAS 495 −0.0002 0.0001 1 [0.999,1.000] 0.1358 495 −0.0001 0.0001 1 [1.000,1.000] 0.615
ZBI 521 −0.004 0.0057 0.996 [0.985,1.007] 0.4787 521 0.0252 0.0059 1.026 [1.014,1.037] < 0.001
Caregiver’s awareness (no) 520 −1.7397 0.2144 0.176 [0.115,0.267] < 0.0001
CAS Caregiver activity scale, CDR Clinical dementia rating, CDR-SOB Clinical dementia rating-sum of boxes, CI Confidence interval, MMSE Mini-mental
state exam, ZBI Zarit burden interview
Table 5 Lack of awareness stratified by baseline clinical dementia rating (CDR)
Baseline CDR 0.5 Baseline CDR 1 Baseline CDR 2 Baseline CDR 3 p-value
n (%) n (%) n (%) n (%)
n 160 188 41 4 < 0.0001
Yes 69 (43.13) 118 (62.77) 37 (90.24) 4 (100.00)
No 91 (56.88) 70 (37.23) 4 (9.76) 0 (0.00)
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are more likely to experience a greater burden [21]. Sev-
eral studies have also reported that spousal caregivers
experience the highest level of burden [16, 21, 22]. Fur-
thermore, some studies have also suggested that
moderate-to-severe disability, which affects a patient’s
ability to perform basic daily activities, is related to a
higher caregiver burden [16, 21, 23, 24].
However, care burden about dementia patients in Asia
is somewhat different, compared to the Western coun-
tries. Ikels followed a sample of 200 elders from 1987 to
1991 in Canton, China and reported that the experience
of giving care to patients with dementia was psycho-
logically less threatening than for people in the United
States [25, 26]. This is possibly because in China there
are cultural concepts that preserve the patients’ sense of
self for longer and caregiving offers a greater intrinsic re-
ward to the family caregiver.
Caregiver burden has previously been defined as “a
multidimensional response to physical, psychological,
emotional, social, and financial stressors associated with
the caregiving experience” [27]. This description differs
from caregiving, which is referred to as the “activities
and experiences involved in providing help and assist-
ance to relatives who are unable to provide for them-
selves”, which does not include the psychological
distress that may come from the act of caregiving [28].
In this study we used both CAS and ZBI to distinguish
caregiving activity from caregiver burden in each
location.
The factors influencing awareness also differed by lo-
cation. The patients’ and caregivers’ awareness were low,
below 50%, in South Korea and China compared to
other locations. This is presumably because South Korea
and China have a relatively more traditional Confucian
culture, which might prevent dementia from being rec-
ognized as an illness [29]. In previous studies, there have
been reports that there is a paucity of information on
dementia in South Korea and China [30, 31]. One longi-
tudinal prospective study of cognitive impairment
among elderly adults showed that the prevalence rate of
dementia in persons aged 65 years and older was 4.6% in
Shanghai [32]. This is much lower than reports from
Western countries where researchers have reported diffi-
culty in recruiting Asian caregivers who perceive a sense
of shame for having a relative with AD [33–35]. Further-
more, Asian caregivers have been shown to delay seeking
an AD diagnosis because they lacked information about
dementia and believed the symptoms were signs of nor-
mal aging [7]. A large proportion of patients with AD
have anosognosia [5, 6], and in our study the greater the
severity of dementia the more their awareness deterio-
rated. With higher MMSE scores observed in South
Korea and China, it might also be considered that anti-
dementia medications could be prescribed earlier before
patients and their family recognize their cognitive dys-
function. Interestingly, in this study, the awareness in
patients was 20–30% lower than the awareness in care-
givers, even though each country has differences in cul-
ture and education. When exploring the emotional
impact of an Alzheimer’s disease diagnosis, although the
majority of patients display signs of an emotional crisis,
a range of responses including lack of insight, active de-
nial, and positive coping responses have been reported
[36]. In addition, a lack of awareness of cognitive func-
tioning deficits is a complex and multidimensional
phenomenon that is also related to a lack of awareness
of functional activity impairments, age, and caregiver
burden [37]. Further analysis of our findings would be
helpful for understanding and developing strategies to
lessen caregiver burden in different Asian countries.
A caregiver’s awareness is strongly influenced by per-
sonal preferences and practicality does not seem to play
a substantive role when making a decision related to
caregiving. Strong family-related emotions can also often
overwhelm rational decision-making, and therefore, in
the case of dementia, medical professionals are required
to play a more explicit role in the decision-making
process by anticipating transitions in care and outlining
options for care and treatment in advance. The assess-
ment of awareness has a high clinical relevance in cases
of dementia, particularly when considering the impact
this has on patients and their family as well as the social
implications of their increased need for medical, social,
legal, and financial support [38, 39].
One of the limitations of this study was the differences
in both patient and caregiver sample sizes in each coun-
try, which is likely to affect the accuracy of any national
comparisons. In particular, the number of South Korean
patients was considerably higher than that of other loca-
tions, which may have influenced our findings. In
addition, the differences in sample sizes from each coun-
try could be due to differences in refusal rate, which
could impart selection bias; however, we were unable to
analyze the refusal rate because of differences between
the sample sizes of each country. Finally, although we
aimed to assess awareness of dementia before the initial
prescription of donepezil, it is possible that some pa-
tients were diagnosed with dementia and provided with
information on their disease before our assessment.
Therefore, these patients are likely to have a higher level
of awareness of their dementia diagnosis at baseline.
Conclusions
This study examined factors that affect caregiver burden
as well as patient and caregiver awareness of dementia
across seven Asian locations. This analysis offers a
unique perspective on patients with dementia and care-
giver management. Ultimately, these data may be useful
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when planning future multinational studies by incorpor-
ating the location and cultural diversity that can influ-
ence the care of patients with dementia.
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University Hospital, Republic of Korea; Kyungpook
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Huashan Hospital, affiliated to Fudan University, China;
Peking Union Medical College Hospital, China; Peking
University Sixth Hospital, China; Renji Hospital Affiliated
to Shanghai Jiao Tong University School of Medicine,
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